not good - 50% down and a quarter of shares turned over!but then AED hasn't performed any better (I remember them being #.00 and doing a special divvie because they had too much money-lol)
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%